Introduction

Max Hodak, co-founder and CEO of Science Corporation, is redefining the relationship between humans and machines. At TechCrunch Disrupt 2026, he presented a vision where technology adapts to us through brain-computer interactions, moving beyond the screen-centric models that have dominated computing for decades.

What Happened

Hodak detailed Science Corporation's progress in developing biohybrid brain-computer interfaces designed to restore vision, enhance cognition, and improve mobility. The company's PRIMA implant, paired with smart glasses, has already helped individuals with severe vision loss perceive visual information through retinal stimulation. Hodak also outlined broader ambitions to repair damaged brain cells, warn of seizures, and treat conditions such as Parkinson's disease.

Why This Matters

The shift from screens to biological interfaces represents a fundamental change in how humans interact with technology. By decoding and stimulating neural activity, Science Corporation aims to create direct pathways between the brain and machines, potentially unlocking treatments for neurological disorders and new ways to engage with digital environments. This approach could redefine accessibility, human performance, and the next generation of computing platforms.

Key Takeaways

  • Science Corporation raised $230 million in a Series C round, valuing the company at $1.5 billion.
  • The PRIMA implant has restored eyesight to patients with severe vision loss using a subretinal chip and camera-equipped glasses.
  • Hodak's work extends beyond restoration, targeting neural repair, seizure warning, and Parkinson's disease intervention.
  • The company is preparing for first-in-human trials of its biohybrid brain-computer interface in the United States.
  • Hodak's vision aligns with a broader industry move toward neurotechnology that adapts to the user rather than requiring the user to adapt to the device.

Conclusion

As Science Corporation advances toward human trials, Hodak's appearance at Disrupt 2026 signals a pivotal moment for the neurotechnology sector. Whether you're a founder, investor, or simply curious about the next evolution of human-computer interaction, the transition from screen to brain-based interfaces promises to reshape industries, improve quality of life, and open new frontiers for innovation.